Workflow
新产业
icon
Search documents
第十八届中国工业论坛在京召开 共探新型工业化发展之路
Zheng Quan Ri Bao Wang· 2025-12-17 12:16
Group 1 - The 18th China Industrial Forum was held in Beijing, focusing on "integrated innovation for a strong industry," emphasizing smart, green, and integrated development [1] - The forum gathered government leaders, experts, and industry leaders to create a dialogue platform for high-quality industrial development in China [1] - The Vice Chairman of the National Committee of the Chinese People's Political Consultative Conference highlighted that "integrated innovation" is key for industrial upgrading and new competitive advantages [1] Group 2 - The President of the China Industrial Economic Federation emphasized the need for advancements in artificial intelligence, green low-carbon transformation, and deep integration of technology and industry [2] - The focus on AI should enhance foundational capabilities such as data, networks, computing power, and algorithms to boost the AI industry [2] - The "14th Five-Year Plan" aims for carbon peak, requiring industries to optimize energy structures and promote green factories [2] Group 3 - The Secretary of the China Enterprise Confederation stressed that manufacturing is core to building a modern industrial system and that Chinese manufacturing firms are increasingly represented in the global top 500 [3] - The emphasis on smart manufacturing and the role of AI and IoT in transforming traditional industries was highlighted [3] - Collaboration across the industrial chain is essential for the development of small and medium enterprises [3] Group 4 - The Chief Expert from China Energy Construction discussed the importance of energy and power in new industrialization, advocating for the development of renewable energy and storage [4] - A collaborative model involving over a hundred industry partners is being led to accelerate the industrialization of compressed air energy storage [4] - The future of renewable energy in China is projected to lead to significant advancements and a new trillion-level market [4] Group 5 - The China Industrial News released a report on the trends and practices of new quality productivity, indicating significant improvements in technology innovation and industrial competitiveness [5] - Challenges such as cognitive biases and insufficient basic research were identified, necessitating enhanced top-level design and reforms [5] - A new research initiative was launched to explore scenarios involving AI, industrial internet, and robotics to foster new quality productivity [5]
低空经济等产业发展驶入快车道,57个新专业加速高素质技能人才培养
Bei Jing Shang Bao· 2025-12-17 11:12
此外,装备制造、电子与信息是此次增补数量较多的专业大类,包含具身智能机器人技术、具身智能工程技术、航天装备智能装配技术、数字孪生应用技 术、智能体技术应用等专业。相关研究机构此前曾预测,具身智能市场规模有望在2035年突破万亿元,赋能交通物流、工业制造、商业服务等多个领域。猎 聘近日发布的《2025三季度人才供需洞察报告》显示,今年三季度,具身智能领域新发职位同比增长72.86%,平均招聘年薪达33.34万元,薪资更具竞争 力。 随着低空经济、具身智能等产业空前发展以及新消费市场不断扩围,高素质技术人才的培养和市场化需求愈发迫切。近日,教育部对2026年职业教育拟招生 专业设置管理工作进行安排,并公布《2025年职业教育专业目录增补清单》,共包含57个职业教育专业。其中,中职专业3个、高职专科专业31个、职业本 科专业23个,体现了职业教育向高层次、应用型人才培养的倾斜。 新增专业紧密对接当前科技前沿和产业升级需求,聚焦国家重大战略、区域重点产业以及民生紧缺领域对高素质技能人才新需求,覆盖低空经济、具身智能 等前沿领域。 据国家发改委数据,2025年低空经济领域人才缺口高达100万人。其中,无人机操控员的缺口 ...
广州战新产业五年增加值超万亿,占GDP比重超30%
Group 1 - The strategic emerging industries in Guangzhou have grown significantly over the past five years, with an added value exceeding 1 trillion and accounting for over 30% of GDP [1] - The city has implemented over 3,300 industrial projects with investments exceeding 100 million, including 34 projects with investments over 1 billion [3] - Advanced manufacturing's added value now represents 60% of the industrial output above designated size [1] Group 2 - Guangzhou has established six advanced manufacturing clusters and ten service industry clusters, each valued at over 100 billion [3] - The city has approved the construction of two national-level artificial intelligence application pilot bases and has registered 57 large models and over 30 AI professional parks [3] - The integration of digital and intelligent technologies has empowered 510 specialized markets and 70,000 consumer industrial enterprises, leading to the emergence of notable companies like Shein and TEMU [3] Group 3 - Guangzhou is focusing on future industries by aligning with national needs, local capabilities, and market trends, resulting in significant technological advancements [5] - Key breakthroughs in core technologies include the successful launch of the solid rocket "Lijian No. 1" and the trial navigation of the first domestically developed deep-sea drilling vessel [5] - The city is enhancing its modern service industry by improving the quality and efficiency of productive services and expanding its logistics and supply chain capabilities [5] Group 4 - Guangzhou is fostering a "friendly industrial" business environment and has implemented the "Gathering Talents" plan, increasing the number of foreign high-level talents [6] - The city has established various funds totaling 4.1 billion for infrastructure and investment, including a 2 billion infrastructure industry fund and a 1.5 billion investment fund [6] - The area designated for industrial development has expanded to 626.7 square kilometers, supporting the growth of innovation and technology transfer [6]
中金:内外因素引发回调 A股中期向好逻辑未改
Zhi Tong Cai Jing· 2025-12-17 00:20
Group 1 - The core viewpoint of the report indicates that the recent weak performance of the A-share market is influenced by both internal and external factors, with external factors playing a dominant role. Despite this, the underlying logic of the current upward trend remains intact, suggesting a positive mid-term outlook for the A-share market [1][2][3] Group 2 - The report highlights three main investment themes for the current market conditions: 1) Growth sectors such as computing power, optical modules, and cloud computing infrastructure are expected to present opportunities, particularly in domestic markets. Applications in robotics, consumer electronics, intelligent driving, and software are also noted. Additionally, sectors like innovative pharmaceuticals, energy storage, and solid-state batteries are entering a growth cycle [1][6] 2) External demand is identified as a relatively certain growth opportunity, with recommendations to focus on sectors like home appliances, construction machinery, commercial buses, power grid equipment, gaming, and globally priced resources such as non-ferrous metals [1][6] 3) The report suggests monitoring cyclical reversals, particularly in industries approaching supply-demand improvement points or benefiting from policy support, such as chemicals, aquaculture, and new energy [1][6] Group 3 - The report emphasizes that the underlying drivers of the market's upward trend have not changed, with the macro policy shift since last year providing a foundation for stabilizing and recovering the market. Factors such as low interest rates, increased household deposits, and regulatory support for capital markets are highlighted as conducive to market growth [3][4] Group 4 - The report notes that the current market correction may provide a favorable opportunity for positioning ahead of the anticipated market performance in the first half of 2026. Despite limited positive catalysts in the short term, the overall valuation of the A-share market remains attractive compared to global peers and other asset classes [5][6]
科创重塑全球资本格局 境外交易所齐聚广州热议中国资产重估
随着宏观数据持续改善、企业盈利动能逐步恢复、前沿科技加速突破,一场由科技创新主导的中国资产 重估正重塑国际资本配置框架。对全球资本而言,这不仅标志着投资者对中国资产信心的修复,也使 2026年的中国市场具备更具延展性的定价空间。 围绕上述议题,纽约证券交易所中国区主管葛辰皓、香港交易所环球上市服务部副总裁陆琛健、伦敦证 券交易所北京代表处首席代表Jon Edwards、韩国交易所北京代表处首席代表芮兑昊等境外主要交易所 代表,近日齐聚南方财经论坛2025年会,畅谈全球资本变局和中国资产重估的深层次逻辑。 全球资金重新定价中国资产 在DeepSeek、宇树科技等新一代中国科技企业持续刷新全球技术版图之际,全球资本流向出现关键性 变化。多家国际投行、主权基金在最新策略报告中集体上调中国资产权重,认为中国市场正迎来一个由 深刻结构性机遇驱动的关键配置窗口。 2025年,A股攀上十年区间高位,港股主要指数录得阶段性强劲反弹……中国资本市场重新站在全球资 金视野的中心,这背后指向三重力量:经济韧性超预期、金融开放稳步深化以及产业链竞争力的进一步 强化。 在全球不确定性日益增多之际,哪个市场将成为投资"避风港"?数据显示 ...
七部门发文推动产品碳足迹因子数据库建设 为绿色发展筑牢数据根基
Zheng Quan Ri Bao Wang· 2025-12-16 10:55
Group 1 - The "Guidelines" issued by seven departments aim to establish a product carbon footprint factor database by 2027, with a comprehensive system expected by 2030 [1] - The product carbon footprint is a key indicator of environmental impact throughout a product's lifecycle, quantifying greenhouse gas emissions from raw material acquisition to disposal [1] - The implementation of the "Guidelines" is expected to significantly impact high-energy consumption and high-emission industries, particularly in coal, electricity, steel, and non-ferrous metals [2] Group 2 - The establishment of the product carbon footprint factor database will guide companies to focus on carbon reduction across the entire lifecycle, promoting technological innovation and industry structure optimization [2] - The rise of green consumption is driving companies to enhance their green core competitiveness, creating a positive interaction between green consumption and production [3] - The integration of advanced technologies like AI and IoT in the database construction process is anticipated to improve efficiency and data quality, fostering the development of related industries [3][4] Group 3 - The database will standardize carbon footprint calculations in the logistics sector, promoting the optimization of transportation methods and the widespread application of energy-saving logistics technologies [4] - The inclusion of quality data in green finance and procurement scenarios will provide market support for the development of green low-carbon industries [2] - Consumers are increasingly interested in carbon footprint information, leading to a demand for greener products, which will encourage companies to invest more in environmentally friendly technologies and processes [2]
东方财富证券:创新浪潮涌动下 关注医药板块修复与突破
智通财经网· 2025-12-16 08:51
智通财经APP获悉,东方财富证券发布研报称,随着中国创新药License-out项目总金额创下新纪录,临 床前项目占比持续保持高位,ADC、双/多抗、小核酸等新兴疗法,以及代谢领域中肥胖适应症等或为 未来License-out项目的重点方向。我国创新药企业已从高投入低产出的研发探索期过渡到了管线密集收 获期,与此同时商保的发展有望让原先的创新药"单一"支付向多元支付转型。此外,医疗器械2025年招 采端持续复苏,关注设备更新政策与资金落地持续驱动需求释放。 东方财富证券主要观点如下: 标的方面 创新药板块建议关注百济神州(06160)、恒瑞医药(01276)、中国生物制药(01177)、三生制药(01530)/三生 国健(688336.SH)、石药集团(01093)等。医疗器械板块:1)内需修复:建议关注迈瑞医疗(300760.SZ)、 联影医疗(688271.SH)、开立医疗(300633.SZ)、澳华内镜(688212.SH)等;2)出海兑现:建议关注海泰新 光(688677.SH)、新产业(300832.SZ)等;3)脑机接口:建议关注诚益通(300430.SZ)、伟思医疗 (688580.SH)等。 ...
医药行业2026年年度策略报告:从“治疗领域”和“技术平台”双管齐下挖掘创新龙头-20251216
Ping An Securities· 2025-12-16 02:44
Core Insights - The report emphasizes the continuous improvement of the global competitiveness of Chinese innovative pharmaceutical companies, focusing on innovation from both "therapeutic areas" and "technology platforms" [5][6] - The growth of commercial health insurance premiums is expected to provide new payment sources for medical expenses, as the scale of commercial health insurance is projected to reach 977.4 billion yuan by 2024 [29][30] - The report identifies potential therapeutic areas such as metabolic diseases (e.g., weight loss), chronic diseases (e.g., hypertension, hyperlipidemia), and central nervous system diseases (e.g., Alzheimer's, Parkinson's) as key focus areas for innovation [5][38] - Emerging technology platforms like small nucleic acid drugs, radioactive drugs (RDC), and CAR-T therapies are highlighted as significant areas for investment [5][38] Market Review - As of November 15, 2025, the pharmaceutical sector has outperformed the market, with the pharmaceutical index rising by 22.09% compared to a 17.62% increase in the CSI 300 index, resulting in a 4.47 percentage point outperformance [11] - The chemical preparation sector showed the best performance, increasing by 40.52%, followed by medical services (+36.98%) and chemical raw materials (+25.34%) [20] - The overall PE valuation of the pharmaceutical sector is at 30.89 times, which is relatively low compared to historical averages, indicating potential for future growth [22][23] Innovative Drugs - The report notes that the growth of health expenditures in China, which reached 9.06 trillion yuan in 2023, is outpacing GDP growth, indicating a robust market for innovative drugs [26][27] - The analysis of multinational corporations (MNCs) reveals that innovation is a core competitive advantage, with companies like Eli Lilly and Novartis showing significant growth driven by innovative products in advanced technology fields such as GLP-1 and ADC [31][32] - The report highlights the strong sales performance of GLP-1 drugs, with Eli Lilly's Mounjaro generating $6.515 billion in revenue in Q3 2025, reflecting a 109% year-on-year increase [44] CXO and Upstream - The report indicates a slight increase in pharmaceutical financing, with a recovery in business development transactions and H-share IPOs, which is expected to stimulate innovation [5] - The demand for external CXO services is growing, particularly in emerging fields such as peptides and small nucleic acids, while internal CXO orders are also showing signs of recovery [5][39] Medical Devices - The domestic medical device market is currently under pressure due to policy impacts, but improvements are anticipated as companies continue to innovate and expand internationally [5] - The report suggests that the industry fundamentals are expected to improve, with a focus on companies like Mindray Medical and Microelectrophysiology [5][39]
加速推进南京国际科技创新中心建设
Xin Hua Ri Bao· 2025-12-15 23:47
Core Insights - The article emphasizes the need for Jiangsu, particularly Nanjing, to enhance its innovation capabilities and establish itself as a global technology innovation center, as outlined in the 20th National Congress and the 14th Provincial Congress [1] Group 1: Innovation Strategy - Jiangsu aims to leverage technology innovation to drive new productivity during the 14th Five-Year Plan, with Nanjing ranked 9th in the 2024 Global Innovation Index by WIPO [1] - Nanjing possesses significant technological resources and industrial foundations but faces challenges such as a lack of strategic innovation platforms and insufficient funding for innovation transformation [1] Group 2: Infrastructure Development - The establishment of the Zijinshan Laboratory as a national laboratory is prioritized, with a focus on spatial planning and resource allocation to support high-end innovation platforms [2] - A systematic approach is being developed to create a cluster of major national scientific infrastructure, ensuring land supply and financial support at both provincial and municipal levels [2] Group 3: Industry Innovation Landmarks - Nanjing is exploring the creation of "6G City" to lead in 6G technology and related industries, aiming to establish impactful innovation brands [3] - Support is being provided for key industrial clusters such as robotics and innovative pharmaceuticals to enhance their competitiveness and international influence [3] Group 4: Collaborative Innovation Ecosystem - A comprehensive innovation engine is being developed, drawing on successful models from other cities to create a collaborative ecosystem centered around the Zijinshan Science City [4] - Mechanisms for cross-regional collaboration and resource sharing are being established to facilitate the integration of education, finance, and industry [4] Group 5: Infrastructure Support - There is a focus on addressing the hardware needs of major research facilities, including optimizing underground utilities and transportation [5] Group 6: Innovation and Investment Synergy - The government is acting as a facilitator to connect top resources with local industries, enhancing the capacity for technology transfer and commercialization [6] - Initiatives are being taken to strengthen the role of enterprises in innovation, promoting collaboration between leading companies and research institutions [6] Group 7: Capital Investment Strategies - A dual approach of government and market-driven investment is being implemented to support technology innovation, including the establishment of venture capital funds [7] - Efforts are being made to attract national venture capital headquarters and financial institutions to enhance the capital landscape for technology startups [7]
天保基建:目前拥有天保智谷生物医药产业园和天津综保智汇城2个产业园区
Zheng Quan Ri Bao Wang· 2025-12-15 14:11
Core Viewpoint - Tianbao Infrastructure (000965) is focusing on the development of two industrial parks, emphasizing its commitment to the biopharmaceutical and health sectors [1] Group 1: Company Overview - The company currently operates two industrial parks: Tianbao Zhigu Biopharmaceutical Industrial Park and Tianjin Comprehensive Bonded Zhihui City [1] - Tianbao Zhigu Biopharmaceutical Industrial Park is positioned around biopharmaceuticals and the health theme [1] Group 2: Project Details - The first phase of the Tianjin Comprehensive Bonded Zhihui City project includes a bonded research and development center, themed around biopharmaceuticals in the Tianjin Port bonded zone [1] - The R&D center aims to create a distinctive innovation platform to support and attract investment [1]